SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-21-000005
Filing Date
2021-12-01
Accepted
2021-12-01 07:04:46
Documents
14
Period of Report
2021-12-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tsvt-20211201.htm   iXBRL 8-K 34071
2 EX-99.1 exhibit99120211201.htm EX-99.1 61532
6 image_0.jpg GRAPHIC 31087
  Complete submission text file 0001860782-21-000005.txt   288519

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tsvt-20211201.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tsvt-20211201_lab.xml EX-101.LAB 25131
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tsvt-20211201_pre.xml EX-101.PRE 13049
7 EXTRACTED XBRL INSTANCE DOCUMENT tsvt-20211201_htm.xml XML 11614
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 211461335
SIC: 2834 Pharmaceutical Preparations